Migraine prophylaxis: what is new and what we need?

A COMPARISON BETWEEN PLACEBO, PIZOTIFEN AND 1-ISOPROPYL-3-HYDROXY-5-SEMICARBAZONO-6-OXO-2.3.5.6.-TETRAHYDROINDOL (DIVASCAN®) IN MIGRAINE PROPHYLAXIS

(2010) P. O. Osterman   ACTA NEUROLOGICA SCANDINAVICA

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

(2010) SK Aurora et al.   CEPHALALGIA

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

(2010) HC Diener et al.   CEPHALALGIA

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

(2010) David W. Dodick et al.   HEADACHE

Telmisartan in Migraine Prophylaxis: A Randomized, Placebo-Controlled Trial

(2009) HC Diener et al.   CEPHALALGIA

Role of Antiepileptic Drugs as Preventive Agents for Migraine

(2009) Michail Vikelis et al.   CNS DRUGS

Origin of pain in migraine: evidence for peripheral sensitisation

(2009) Jes Olesen et al.   LANCET NEUROLOGY

Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study

(2009) Anne W Hauge et al.   LANCET NEUROLOGY

Efficacy of Botulinum Toxin Type A for the Prophylaxis of Episodic Migraine Headaches: A Meta-analysis of Randomized, Double-Blind, Placebo-Controlled Trials

(2009) Adam J Shuhendler et al.   PHARMACOTHERAPY

Pathophysiological basis of migraine prophylaxis

(2009) Francesca Galletti et al.   PROGRESS IN NEUROBIOLOGY

Attack Frequency and Disease Duration as Indicators for Brain Damage in Migraine

(2008) Nicole Schmitz et al.   HEADACHE